Showing results (161-170 of 701) with videos related to

Sort By:
Pageof 71
Therapeutic Drug Monitoring|February 1, 1992
Postmortem concentrations of phenytoin in different regions of the brain and in the serum: analysis of autoptic specimens from 24 epileptic patientsB Rambeck, R Schnabel, T May, et al.
Histopathology|March 1, 2012
Angiogenin up-regulation correlates with adverse clinicopathological and biological factors, increased microvascular density and poor patient outcome in neuroblastomasJosiah V Dungwa, Urmila Uparkar, Margaret T May, et al.
Diabetes & Metabolism|February 5, 1999
Protease inhibitors, diabetes mellitus and blood lipidsL Meyer, C Rabaud, O Ziegler, et al.
British Journal of Pharmacology|September 13, 2013
Allosteric interactions at adenosine A(1) and A(3) receptors: new insights into the role of small molecules and receptor dimerizationStephen J Hill, Lauren T May, Barrie Kellam, et al.
Therapeutic Drug Monitoring|November 1, 1990
Postmortem serum protein binding and brain concentrations of antiepileptic drugs in autoptic specimens from 45 epileptic patientsB Rambeck, R Schnabel, T May, et al.
Brain & Spine|January 1, 2024
Probing artificial intelligence in neurosurgical training: ChatGPT takes a neurosurgical residents written examA Bartoli, A T May, A Al-Awadhi, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)|July 1, 1995
Changes of G-protein levels in platelet membranes from alcoholics during short-term and long-term abstinenceB Lichtenberg-Kraag, T May, L G Schmidt, et al.
European Neurology|January 1, 1990
Valproic acid-induced carbamazepine-10,11-epoxide toxicity in children and adolescentsB Rambeck, A Sälke-Treumann, T May, et al.
BMJ Open|February 3, 2018
Predicting prostate cancer progression: protocol for a retrospective cohort study to identify prognostic factors for prostate cancer outcomes using routine primary care dataSamuel W D Merriel, Margaret T May, Richard M Martin
Gene|October 4, 2022
Adaptive resistance is not responsible for long-term drug resistance in a cellular model of triple negative breast cancerUttom Kumar, Marcos Castellanos-Uribe, Sean T May, et al.
Pageof 71